Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2013
  • Volume: 6
  • Issue: 5

Nanoparticles for Brain Targeting

  • Author:
  • Vihar Gadhvi, Kachariya Brijesh, Amit Gupta, Komal Roopchandani, Nirav Patel
  • Total Page Count: 5
  • Page Number: 454 to 458

Mahatma Gandhi College of Pharmaceutical Sciences, ISI-15 (A) RIICO Institutional Area, Sitapura, Tonk Road, Jaipur-302022 (Rajasthan)

*Corresponding Author E-mail: gadhavi.vihar@gmail.com

Online published on 31 October, 2013.

Abstract

Nanoparticles are solid colloidal particles ranging in size from 1 to 1000 nm that are utilized as drug delivery agents. The blood brain barrier represents an insurmountable obstacle for a large number of drugs including antibiotics, antineoplastic and a variety of CNS active drugs especially neuropeptides. One of the possibilities to overcome this barrier is a drug delivery to brain using nanoparticles. The use of nanoparticles to deliver drugs to the brain across the blood brain barrier may provide a significant advantage to current strategies. The primary advantage of nanoparticles carrier technology is that nanoparticles mask the blood brain barrier limiting the characteristics of the therapeutics, drug molecules and it also decreasing peripheral toxicity by causing slow drug release in the brain. The nanoparticles may be especially helpful for the treatment of the disseminated and very aggressive brain tumors. The mechanism of nanoparticles mediated transport of drugs is mostly endocytosis by endothelial cells lining the brain blood capillaries. Physiological factors such as phagocytic activity of reticulo endothelial system and opsonization may limit the amount of brain delivered drug.

Keywords

Nanoparticles, brain targeting, colloidal particles, neuropeptides, endocytosis, anti-neoplastic